🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free →

Ipamorelin

For In-Vitro Laboratory Research Use Only • Not for Human or Veterinary Use

Ipamorelin Peptide

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) studied as a selective ghrelin/growth hormone secretagogue receptor (GHSR-1a) agonist in receptor-binding and pituitary signalling research. Supplied for in-vitro laboratory research use only, with batch verification and Certificate of Analysis (COA) documentation.

£17.99 – £35.99 / vialFrom £15.29 / vial (15% Multi-Vial Savings)

🧪 MULTI-VIAL RESEARCH SAVINGS Buy 2 Save 10% · Buy 3+ Save 15%
1 Vial Standard £17.99 / vial
Buy 2 Vials Save 10% £16.19 / vial
Buy 3+ Vials Save 15% £15.29 / vial
Mix & match vials — 10% off 2 vials and 15% off 3+ vials auto-applies in your basket + Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99.
💧 Reconstitution Bundle: add 10ml Bacteriostatic Water (£5.99) with any lyophilised peptide — FREE on orders over £100.
💧 + Add 10ml BAC Water (£5.99 / Free £100+)
Ways to pay. You place the order first, then pay by a secure payment link (all major credit and debit cards including Visa, Mastercard and American Express, Apple Pay, Google Pay, PayPal including Pay in 3, or a Zilch virtual card) or by UK bank transfer.

FOR IN-VITRO LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

About Ipamorelin

Ipamorelin is a synthetic pentapeptide, a chain of five amino acids with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. It includes non-standard amino acids: Aib (α-aminoisobutyric acid) and D-2-Nal (3-(2-naphthyl)-D-alanine). It belongs to a class of compounds known as growth hormone secretagogues, which act at the ghrelin (growth hormone secretagogue) receptor to stimulate growth hormone release from the pituitary gland [1]. It has the molecular formula C38H49N9O5 and a molecular weight of approximately 711.9 g/mol.

Ipamorelin has not been approved as a medicine by the MHRA, the FDA or any other regulator. The product sold here is a research compound for laboratory use only.

Related research compound: CJC-1295 (DAC-free), a synthetic analogue of growth hormone-releasing hormone (GHRH) that acts at a different receptor from Ipamorelin.

Areas of research

Ipamorelin was first described in 1998. Published research includes:

  • its original pharmacological characterisation in rat pituitary cells, rats and pigs, where it was reported to be selective for growth hormone release, with no significant effect on ACTH or cortisol under the conditions tested [1]
  • bone growth measurements in a 15-day study in adult female rats [2]
  • a pharmacokinetic and pharmacodynamic modelling study in healthy male volunteers [3]
  • a small phase 2 proof-of-concept trial in postoperative ileus, which found no significant difference from placebo on its efficacy endpoints [4]

Most published work on ipamorelin is preclinical, and the clinical data are limited to small early-phase studies. They are cited here for scientific background only.

Product specifications

Form Lyophilised (freeze-dried) powder in a sealed vial
Sizes 2mg, 5mg, 10mg
Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 (5 amino acids)
Molecular formula C38H49N9O5
Molecular weight approx. 711.9 g/mol
Purity COA shown is for the 10mg batch. The current 10mg COA reports HPLC purity of >99.7%.

Storage and handling

Storage & Handling — Corex Vitality™ research vials

  • As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
  • Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
  • Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
  • Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
  • Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
  • Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
  • Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.

Compound note: Basic pentapeptide with bulky aromatic residues. Usually water-friendly; a trace of dilute acetic acid helps if it is slow.

For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.

Quality and testing

Ipamorelin batches we sell have a published third-party HPLC Certificate of Analysis. On Lingda reports the Client is the manufacturer/supplier; we publish the file exactly as issued. The COA shown is for the 10mg batch; no separate COA has been issued for the 5mg size. For the 2mg size, the COA is published when this batch arrives. You can also browse every published certificate on our COA and verification page.

Ipamorelin identity and batch questions

What do “Aib” and “D-2-Nal” mean in the sequence?

They are non-standard amino acids. Aib is α-aminoisobutyric acid and D-2-Nal is 3-(2-naphthyl)-D-alanine. They are part of the five-residue sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 shown in the specifications table.

Is Ipamorelin the same compound as CJC-1295?

No. They are separate synthetic peptides with different sequences, and they act at different receptors. Each has its own listing and certificate. See CJC-1295 (DAC-free).

Does the 10mg certificate also cover the 5mg size?

No. The COA shown is for the 10mg batch, and no separate COA has been issued for the 5mg size. A certificate describes only the batch that was tested. Match your batch identifier on our verification page.

For laboratory research use only. Not for human consumption.

Research use only

For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

Related reading

References

  1. Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PubMed 9849822
  2. Johansen PB, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1999. PubMed 10373343
  3. Gobburu JV, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999. PubMed 10496658
  4. Beck DE, et al. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in experimental study cohorts. Int J Colorectal Dis. 2014. PubMed 25331030

Additional information

Size

2mg, 5mg, 10mg

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cover of the free guide: How to read a COA

Free guide

How to read a COA

Get it by email, plus our research updates. No spam, unsubscribe any time.

We will email you to confirm first, then send the guide. We use your name and email only to send you these emails. Privacy policy. For laboratory research use only.

Listed on PepmarketVerified on PeptideReview
🎬 Scientific Explainer Video · What It Is For & How It Works

Ipamorelin — Laboratory Mechanism & Research Overview

⬇ Download Video (MP4) All Peptide Videos →
🔬 What Is This Peptide Researched For?
  • Investigating selective Growth Hormone Secretagogue Receptor (GHS-R1a) activation on somatotrophs
  • Studying pulsatile GH release mechanics without ACTH, cortisol or prolactin off-target elevation
  • Evaluating synergistic dual-receptor protocols alongside GHRH analogues such as CJC-1295 (DAC-free)
⚙️ How Does It Work? (Mechanism of Action)
1. Selective GHS-R1a Binding: Binds the ghrelin/growth-hormone secretagogue receptor (GHS-R1a) with high specificity.
2. Gq / Phospholipase C / IP3 Cascade: Triggers intracellular Ca2+ mobilisation via the PLC-IP3-PKC pathway (distinct from GHRH cAMP).
3. Clean Pulsatile Vesicle Exocytosis: Drives somatotroph exocytosis while sparing corticotroph and lactotroph axes.
📚 Peer-Reviewed Literature · PubMed Indexed

Published Research — Peer-Reviewed Receptor & Pathway Studies

NCBI PubMed Database ↗ Verify Batch COAs →

Ipamorelin (Selective GHSR-1a Pentapeptide)

  1. [1] Raun K et al. · Eur J Endocrinol (1998)

    Foundational receptor-pharmacology characterisation of the synthetic pentapeptide ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) in primary rat pituitary cells and in-vivo models, demonstrating high GHSR-1a selectivity without ACTH or cortisol elevation.

    PMID: 9849822 ↗ DOI: 10.1530/eje.0.1390552 ↗
  2. [2] Ankersen M et al. · J Med Chem (1998)

    Medicinal chemistry and structure-activity relationship study of ipamorelin pentapeptide analogues evaluating N-methylated backbones and aromatic side-chain conformations in rat pituitary cell assays.

    PMID: 9733495 ↗ DOI: 10.1021/jm9801962 ↗
  3. [3] Johansen PB et al. · Growth Horm IGF Res (1999)

    Pre-clinical rodent study quantifying concentration-dependent longitudinal bone growth rate and somatotroph hormone release following administration of the selective pentapeptide secretagogue ipamorelin.

    PMID: 10373343 ↗ DOI: 10.1054/ghir.1999.9998 ↗
  4. [4] Svensson J et al. · J Endocrinol (2000)

    Dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) study in rodent models examining cortical and cancellous bone mineral content under GHSR-1a agonist stimulation.

    PMID: 10828840 ↗ DOI: 10.1677/joe.0.1650569 ↗

CJC-1295 (DAC-Free / Mod GRF 1-29)

  1. [1] Theriault Y et al. · Biopolymers (1988)

    Two-dimensional 1H-NMR spectroscopy and distance-geometry structural determination of the biologically active 29-amino-acid N-terminal domain of growth hormone-releasing factor, identifying two α-helical regions.

    PMID: 3149201 ↗ DOI: 10.1002/bip.360271204 ↗
  2. [2] Stepień T et al. · Neuropeptides (2009)

    In-vitro cell culture study demonstrating specific GHRH(1-29)-NH2 receptor binding, cellular proliferation, and vascular endothelial growth factor (VEGF) secretion in neuroendocrine cell lines.

    PMID: 19747727 ↗ DOI: 10.1016/j.npep.2009.08.005 ↗
  3. [3] Memdouh S et al. · Drug Test Anal (2021)

    Analytical review of synthetic GHRH(1-29) analogues including CJC-1295 and sermorelin, covering solid-phase sequence modifications, proteolytic cleavage pathways, and high-resolution mass spectrometry identification.

    PMID: 34665524 ↗ DOI: 10.1002/dta.3183 ↗
  4. [4] Uçaktürk E et al. · J Pharm Biomed Anal (2026)

    Validation of a nano-LC–quadrupole/Orbitrap high-resolution mass spectrometry workflow for separating and quantifying intact GHRH(1-29) analogues and their N-terminal enzymatic fragments.

    PMID: 41138283 ↗ DOI: 10.1016/j.jpba.2025.117207 ↗

References are provided for scientific context only. All Corex Vitality™ compounds are supplied strictly for in-vitro laboratory research use (RUO).